Crossref
Optimising collaboration between lead identifiers and genomic analysts in pharma and biotech companies
The Biomedical & Life Sciences Collection · 29.10.2026 · 2026 (10) · e1008422
DOI: 10.69645/xqjb5671 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Biomedical & Life Sciences Collection, online erschienen am 29.10.2026. Verfasst von Fritz Sedlazeck.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Sedlazeck, F. (2026). Optimising collaboration between lead identifiers and genomic analysts in pharma and biotech companies. The Biomedical & Life Sciences Collection, 2026(10), e1008422. https://doi.org/10.69645/xqjb5671
Vancouver
Sedlazeck F. Optimising collaboration between lead identifiers and genomic analysts in pharma and biotech companies. The Biomedical & Life Sciences Collection. 2026;2026(10):e1008422. doi:10.69645/xqjb5671
BibTeX
@article{Sedlazeck2026,
author = {Sedlazeck, Fritz},
title = {Optimising collaboration between lead identifiers and genomic analysts in pharma and biotech companies},
journal = {The Biomedical & Life Sciences Collection},
year = {2026},
volume = {2026},
number = {10},
pages = {e1008422},
doi = {10.69645/xqjb5671}
}
EUVIMED